16th Nov 2007 15:31
Allergy Therapeutics PLC16 November 2007 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Director/PDMR Shareholding Allergy Therapeutics announces that on 16 November 2007 Dr Christian Gratz, adirector of the Company, exercised share options over 106,000 ordinary shares of0.1 pence each ("Ordinary Shares") awarded pursuant to the Allergy Therapeutics1998 Share Option Scheme and Allergy Therapeutics 2001 and Share Option Schemeas follows: Name of scheme: Allergy Therapeutics 1998 Share Option SchemeDate of grant: 20 October 2000Date of exercise: 16 November 2007Exercise price: 0.1 penceNumber of shares exercised: 6,000 Name of scheme: Allergy Therapeutics 2001 Share Option SchemeDate of grant: 18 December 2002Date of exercise: 16 November 2007Exercise price: 5.0 penceNumber of shares exercised: 100,000 Following the above transactions Dr Gratz now holds share options over 2,250,000Ordinary Shares. In addition Dr Gratz holds 510,658 Ordinary Shares,representing 0.62 per cent. of the total voting rights of the Company. Enquiries: Allergy Therapeutics plc +44 (0) 1903 845 820Ian Postlethwaite This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.